(Q22008679)

activin receptor signaling pathway

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

J J Lebrun

J J

Lebrun

1 reference

7 February 2023

K Takabe

series ordinal

author given names

author last names

Takabe

1 reference

7 February 2023

Y Chen

series ordinal

author given names

author last names

Chen

1 reference

7 February 2023

W Vale

series ordinal

author given names

author last names

Vale

1 reference

Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts

7 February 2023

language of work or name

English

0 references

publication date

January 1999

0 references

published in

Molecular Endocrinology

0 references

volume

0 references

issue

0 references

page(s)

15-23

0 references

cites work

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors.

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

Xenopus Mad proteins transduce distinct subsets of signals for the TGF beta superfamily

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

From receptor to nucleus: the Smad pathway

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

A WD-domain protein that is associated with and phosphorylated by the type II TGF-beta receptor

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

A human Mad protein acting as a BMP-regulated transcriptional activator

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

Receptor-associated Mad homologues synergize as effectors of the TGF-beta response

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways.

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

Smad6 inhibits signalling by the TGF-beta superfamily

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

Mad-related genes in the human

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

Cloning and characterization of a transmembrane serine kinase that acts as an activin type I receptor

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

Regulation of transforming growth factor beta- and activin-induced transcription by mammalian Mad proteins

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

Smad8 mediates the signaling of the ALK-2 [corrected] receptor serine kinase

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12.

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

Mechanism of TGFbeta receptor inhibition by FKBP12

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

The p21(RAS) farnesyltransferase alpha subunit in TGF-beta and activin signaling

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

Specific interaction of type I receptors of the TGF-beta family with the immunophilin FKBP-12

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

Determination of type I receptor specificity by the type II receptors for TGF-beta or activin

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

Activation of signalling by the activin receptor complex

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4

1 reference

https://api.crossref.org/works/10.1210%2FMEND.13.1.0218

7 January 2021

Identifiers

DOI

10.1210/MEND.13.1.0218

0 references

10.1210/ME.13.1.15

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017